Apigenin 7-0-β-d-(4-caffeoyl) for COVID-19

 Apigenin 7-0-β-d-(4-caffeoyl) has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed apigenin 7-0-β-d-(4-caffeoyl) in detail.